fanta.bio Sample: CNhs11932
17543 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1305 / 17767 (7.3%) | 379 / 177670 (0.2%) | −324.0 | −324.0 | 34.43 |
| HIF1A SRX11007095 | HK-2 Kidney | 2583 / 17767 (14.5%) | 848 / 177670 (0.5%) | −324.0 | −324.0 | 30.46 |
| TP53 SRX19538268 | U2OS Bone | 474 / 17767 (2.7%) | 161 / 177670 (0.1%) | −324.0 | −324.0 | 29.44 |
| TP53 SRX19538274 | U2OS Bone | 471 / 17767 (2.7%) | 164 / 177670 (0.1%) | −324.0 | −324.0 | 28.72 |
| TP53 SRX19538276 | U2OS Bone | 480 / 17767 (2.7%) | 169 / 177670 (0.1%) | −324.0 | −324.0 | 28.40 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1924 / 17767 (10.8%) | 698 / 177670 (0.4%) | −324.0 | −324.0 | 27.56 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1867 / 17767 (10.5%) | 764 / 177670 (0.4%) | −324.0 | −324.0 | 24.44 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2595 / 17767 (14.6%) | 1154 / 177670 (0.6%) | −324.0 | −324.0 | 22.49 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2546 / 17767 (14.3%) | 1135 / 177670 (0.6%) | −324.0 | −324.0 | 22.43 |
| TP53 SRX19538279 | Osteoblasts Bone | 580 / 17767 (3.3%) | 259 / 177670 (0.1%) | −324.0 | −324.0 | 22.39 |
| HIF1A SRX20663235 | HK-2 Kidney | 557 / 17767 (3.1%) | 268 / 177670 (0.2%) | −324.0 | −324.0 | 20.78 |
| SCML2 SRX644728 | 293 Kidney | 1483 / 17767 (8.3%) | 747 / 177670 (0.4%) | −324.0 | −324.0 | 19.85 |
| FOXP1 SRX736067 | LNCAP Prostate | 1815 / 17767 (10.2%) | 1225 / 177670 (0.7%) | −324.0 | −324.0 | 14.82 |
| MYH11 SRX265221 | ME-1 Blood | 917 / 17767 (5.2%) | 623 / 177670 (0.4%) | −324.0 | −324.0 | 14.72 |
| BRD4 SRX9419935 | BT-474 Breast | 3895 / 17767 (21.9%) | 2777 / 177670 (1.6%) | −324.0 | −324.0 | 14.03 |
| BRD4 SRX9419937 | BT-474 Breast | 3903 / 17767 (22.0%) | 2788 / 177670 (1.6%) | −324.0 | −324.0 | 14.00 |
| MED1 SRX9419944 | BT-474 Breast | 3780 / 17767 (21.3%) | 2779 / 177670 (1.6%) | −324.0 | −324.0 | 13.60 |
| MED1 SRX9419945 | BT-474 Breast | 3834 / 17767 (21.6%) | 2827 / 177670 (1.6%) | −324.0 | −324.0 | 13.56 |
| MED1 SRX9419946 | BT-474 Breast | 3922 / 17767 (22.1%) | 2959 / 177670 (1.7%) | −324.0 | −324.0 | 13.25 |
| BRD4 SRX9419938 | BT-474 Breast | 3910 / 17767 (22.0%) | 2960 / 177670 (1.7%) | −324.0 | −324.0 | 13.21 |
| BRD4 SRX9419936 | BT-474 Breast | 3904 / 17767 (22.0%) | 2960 / 177670 (1.7%) | −324.0 | −324.0 | 13.19 |
| MED1 SRX9419947 | BT-474 Breast | 3810 / 17767 (21.4%) | 2947 / 177670 (1.7%) | −324.0 | −324.0 | 12.93 |
| EZH2 SRX2146136 | LNCAP Prostate | 8475 / 17767 (47.7%) | 8264 / 177670 (4.7%) | −324.0 | −324.0 | 10.26 |
| BRD4 SRX736201 | 90-8TL Neural | 6524 / 17767 (36.7%) | 6891 / 177670 (3.9%) | −324.0 | −324.0 | 9.47 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 756 / 17767 (4.3%) | 935 / 177670 (0.5%) | −324.0 | −324.0 | 8.09 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1993 / 17767 (11.2%) | 2793 / 177670 (1.6%) | −324.0 | −324.0 | 7.14 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1553 / 17767 (8.7%) | 3749 / 177670 (2.1%) | −324.0 | −324.0 | 4.14 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1782 / 17767 (10.0%) | 5332 / 177670 (3.0%) | −324.0 | −324.0 | 3.34 |
| AGO2 SRX4708039 | Hep G2 Liver | 2153 / 17767 (12.1%) | 7754 / 177670 (4.4%) | −324.0 | −324.0 | 2.78 |
| PBX4 SRX2731658 | PC-3 Prostate | 1013 / 17767 (5.7%) | 27990 / 177670 (15.8%) | −324.0 | −324.0 | 0.36 |
| TP53 SRX19538280 | Osteoblasts Bone | 459 / 17767 (2.6%) | 192 / 177670 (0.1%) | −318.1 | −315.1 | 23.91 |
| TP53 SRX19538267 | U2OS Bone | 425 / 17767 (2.4%) | 148 / 177670 (0.1%) | −309.8 | −306.8 | 28.72 |
| TP53 SRX19538275 | U2OS Bone | 427 / 17767 (2.4%) | 170 / 177670 (0.1%) | −300.1 | −297.1 | 25.12 |
| TP53 SRX19538281 | Osteoblasts Bone | 480 / 17767 (2.7%) | 285 / 177670 (0.2%) | −296.1 | −293.1 | 16.84 |
| FOS SRX150477 | MCF 10A Breast | 661 / 17767 (3.7%) | 20861 / 177670 (11.7%) | −295.5 | −292.5 | 0.32 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 439 / 17767 (2.5%) | 205 / 177670 (0.1%) | −294.1 | −291.1 | 21.41 |
| FOS SRX150478 | MCF 10A Breast | 702 / 17767 (4.0%) | 21383 / 177670 (12.0%) | −291.4 | −288.4 | 0.33 |
| IRF3 SRX11453858 | Hep G2 Liver | 344 / 17767 (1.9%) | 62 / 177670 (0.0%) | −288.0 | −285.0 | 55.48 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 617 / 17767 (3.5%) | 19900 / 177670 (11.2%) | −287.6 | −284.7 | 0.31 |
| TP53 SRX19538273 | U2OS Bone | 405 / 17767 (2.3%) | 156 / 177670 (0.1%) | −287.3 | −284.4 | 25.96 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 689 / 17767 (3.9%) | 927 / 177670 (0.5%) | −282.7 | −279.8 | 7.43 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 714 / 17767 (4.0%) | 1020 / 177670 (0.6%) | −281.5 | −278.6 | 7.00 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1027 / 17767 (5.8%) | 25540 / 177670 (14.4%) | −269.0 | −266.1 | 0.40 |
| TP53 SRX19538269 | U2OS Bone | 507 / 17767 (2.9%) | 439 / 177670 (0.2%) | −266.4 | −263.5 | 11.55 |
| YAP1 SRX757325 | H2052 Lung | 781 / 17767 (4.4%) | 21563 / 177670 (12.1%) | −259.8 | −256.9 | 0.36 |
| RUNX1 SRX2513054 | 293 Kidney | 3497 / 17767 (19.7%) | 18621 / 177670 (10.5%) | −255.6 | −252.8 | 1.88 |
| FOXA1 SRX4815197 | MCF-7 Breast | 747 / 17767 (4.2%) | 20839 / 177670 (11.7%) | −253.6 | −250.8 | 0.36 |
| FOXA1 SRX176862 | MCF-7 Breast | 380 / 17767 (2.1%) | 14669 / 177670 (8.3%) | −248.0 | −245.2 | 0.26 |
| 5-mC SRX882970 | LNCAP Prostate | 3101 / 17767 (17.5%) | 15879 / 177670 (8.9%) | −247.2 | −244.3 | 1.95 |
| TP53 SRX19538270 | U2OS Bone | 480 / 17767 (2.7%) | 435 / 177670 (0.2%) | −246.6 | −243.8 | 11.03 |
| FOS SRX4192880 | MCF 10A Breast | 520 / 17767 (2.9%) | 16954 / 177670 (9.5%) | −245.0 | −242.2 | 0.31 |
| KAT6A SRX20971022 | Fibroblasts Others | 301 / 17767 (1.7%) | 65 / 177670 (0.0%) | −244.0 | −241.2 | 46.31 |
| IRF3 SRX11453861 | Hep G2 Liver | 302 / 17767 (1.7%) | 67 / 177670 (0.0%) | −243.6 | −240.8 | 45.07 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2284 / 17767 (12.9%) | 10174 / 177670 (5.7%) | −243.1 | −240.3 | 2.24 |
| YAP1 SRX757326 | H2052 Lung | 683 / 17767 (3.8%) | 19314 / 177670 (10.9%) | −237.9 | −235.1 | 0.35 |
| TP53 SRX19538282 | Osteoblasts Bone | 416 / 17767 (2.3%) | 300 / 177670 (0.2%) | −237.4 | −234.6 | 13.87 |
| ESR1 SRX7624157 | MCF-7 Breast | 843 / 17767 (4.7%) | 21690 / 177670 (12.2%) | −236.5 | −233.8 | 0.39 |
| 5-mC SRX882968 | LNCAP Prostate | 3037 / 17767 (17.1%) | 15740 / 177670 (8.9%) | −234.0 | −231.2 | 1.93 |
| Epitope tags SRX10549776 | K-562 Blood | 1499 / 17767 (8.4%) | 5360 / 177670 (3.0%) | −231.3 | −228.6 | 2.80 |
| ESR1 SRX371478 | MCF-7 Breast | 395 / 17767 (2.2%) | 14396 / 177670 (8.1%) | −230.7 | −228.0 | 0.27 |
| FOS SRX150517 | MCF 10A Breast | 546 / 17767 (3.1%) | 16898 / 177670 (9.5%) | −230.3 | −227.5 | 0.32 |
| FOXA1 SRX176863 | MCF-7 Breast | 371 / 17767 (2.1%) | 13923 / 177670 (7.8%) | −228.9 | −226.1 | 0.27 |
| FOXA1 SRX1161177 | MCF-7 Breast | 302 / 17767 (1.7%) | 12666 / 177670 (7.1%) | −228.2 | −225.5 | 0.24 |
| JUNB SRX8488088 | SUM 229PE Breast | 624 / 17767 (3.5%) | 18048 / 177670 (10.2%) | −227.5 | −224.8 | 0.35 |
| ESR1 SRX4367193 | MCF-7 Breast | 1086 / 17767 (6.1%) | 24840 / 177670 (14.0%) | −226.9 | −224.2 | 0.44 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 215 / 17767 (1.2%) | 10903 / 177670 (6.1%) | −224.4 | −221.7 | 0.20 |
| FOXA1 SRX3931044 | MCF-7 Breast | 718 / 17767 (4.0%) | 19297 / 177670 (10.9%) | −221.8 | −219.1 | 0.37 |
| ESR1 SRX20282961 | MCF-7 Breast | 401 / 17767 (2.3%) | 14200 / 177670 (8.0%) | −221.1 | −218.4 | 0.28 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 367 / 17767 (2.1%) | 13565 / 177670 (7.6%) | −219.6 | −216.9 | 0.27 |
| BRD1 SRX286203 | RKO Digestive tract | 1284 / 17767 (7.2%) | 4274 / 177670 (2.4%) | −219.4 | −216.7 | 3.00 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 362 / 17767 (2.0%) | 13465 / 177670 (7.6%) | −219.2 | −216.5 | 0.27 |
| KAT7 SRX101303 | RKO Digestive tract | 1459 / 17767 (8.2%) | 5306 / 177670 (3.0%) | −218.8 | −216.2 | 2.75 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 541 / 17767 (3.0%) | 742 / 177670 (0.4%) | −218.8 | −216.1 | 7.29 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 526 / 17767 (3.0%) | 693 / 177670 (0.4%) | −218.4 | −215.8 | 7.59 |
| FOS SRX150476 | MCF 10A Breast | 578 / 17767 (3.3%) | 17000 / 177670 (9.6%) | −218.0 | −215.4 | 0.34 |
| GATA3 SRX190239 | MCF-7 Breast | 476 / 17767 (2.7%) | 15357 / 177670 (8.6%) | −218.0 | −215.4 | 0.31 |
| ESR1 SRX7624156 | MCF-7 Breast | 536 / 17767 (3.0%) | 16303 / 177670 (9.2%) | −217.2 | −214.5 | 0.33 |
| CIC SRX13262055 | Astrocytes Neural | 3211 / 17767 (18.1%) | 17598 / 177670 (9.9%) | −213.8 | −211.2 | 1.82 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 416 / 17767 (2.3%) | 14202 / 177670 (8.0%) | −213.1 | −210.5 | 0.29 |
| FOXA1 SRX1161173 | MCF-7 Breast | 240 / 17767 (1.4%) | 11058 / 177670 (6.2%) | −212.9 | −210.3 | 0.22 |
| FOXA1 SRX371482 | MCF-7 Breast | 488 / 17767 (2.7%) | 15371 / 177670 (8.7%) | −212.4 | −209.8 | 0.32 |
| AGO2 SRX6783958 | Hep G2 Liver | 1324 / 17767 (7.5%) | 4618 / 177670 (2.6%) | −211.4 | −208.8 | 2.87 |
| TP53 SRX19538271 | U2OS Bone | 672 / 17767 (3.8%) | 1292 / 177670 (0.7%) | −210.3 | −207.7 | 5.20 |
| AGO2 SRX6783957 | Hep G2 Liver | 1338 / 17767 (7.5%) | 4722 / 177670 (2.7%) | −209.8 | −207.2 | 2.83 |
| FOXA1 SRX1161176 | MCF-7 Breast | 307 / 17767 (1.7%) | 12191 / 177670 (6.9%) | −209.4 | −206.8 | 0.25 |
| ESR1 SRX371469 | MCF-7 Breast | 342 / 17767 (1.9%) | 12799 / 177670 (7.2%) | −209.1 | −206.5 | 0.27 |
| BRPF3 SRX796085 | RKO Digestive tract | 1163 / 17767 (6.5%) | 3753 / 177670 (2.1%) | −207.3 | −204.7 | 3.10 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1495 / 17767 (8.4%) | 5714 / 177670 (3.2%) | −206.8 | −204.2 | 2.62 |
| ESR1 SRX20282960 | MCF-7 Breast | 383 / 17767 (2.2%) | 13403 / 177670 (7.5%) | −205.6 | −203.1 | 0.29 |
| FOXA1 SRX371481 | MCF-7 Breast | 352 / 17767 (2.0%) | 12861 / 177670 (7.2%) | −205.3 | −202.8 | 0.27 |
| 5-mC SRX882965 | LNCAP Prostate | 2461 / 17767 (13.9%) | 12265 / 177670 (6.9%) | −204.7 | −202.1 | 2.01 |
| ESR1 SRX176860 | MCF-7 Breast | 570 / 17767 (3.2%) | 16413 / 177670 (9.2%) | −204.3 | −201.8 | 0.35 |
| ESR1 SRX371479 | MCF-7 Breast | 304 / 17767 (1.7%) | 11959 / 177670 (6.7%) | −203.7 | −201.1 | 0.25 |
| FOXA1 SRX371483 | MCF-7 Breast | 386 / 17767 (2.2%) | 13365 / 177670 (7.5%) | −202.9 | −200.4 | 0.29 |
| BRPF3 SRX796084 | RKO Digestive tract | 1591 / 17767 (9.0%) | 6387 / 177670 (3.6%) | −202.6 | −200.0 | 2.49 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 598 / 17767 (3.4%) | 16780 / 177670 (9.4%) | −202.4 | −199.8 | 0.36 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 499 / 17767 (2.8%) | 15155 / 177670 (8.5%) | −200.5 | −197.9 | 0.33 |
| TLE3 SRX4815191 | MCF-7 Breast | 320 / 17767 (1.8%) | 12101 / 177670 (6.8%) | −198.9 | −196.4 | 0.26 |
| ESR1 SRX176861 | MCF-7 Breast | 587 / 17767 (3.3%) | 16475 / 177670 (9.3%) | −198.5 | −195.9 | 0.36 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 457 / 17767 (2.6%) | 14397 / 177670 (8.1%) | −198.3 | −195.7 | 0.32 |
| ESR1 SRX371471 | ZR-75-1 Breast | 373 / 17767 (2.1%) | 12990 / 177670 (7.3%) | −198.1 | −195.6 | 0.29 |
| BRD4 SRX736204 | 90-8TL Neural | 999 / 17767 (5.6%) | 2974 / 177670 (1.7%) | −197.8 | −195.2 | 3.36 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 507 / 17767 (2.9%) | 15171 / 177670 (8.5%) | −197.2 | −194.7 | 0.33 |
| FOXA1 SRX1161175 | MCF-7 Breast | 244 / 17767 (1.4%) | 10640 / 177670 (6.0%) | −196.4 | −193.8 | 0.23 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1849 / 17767 (10.4%) | 8188 / 177670 (4.6%) | −196.3 | −193.8 | 2.26 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 329 / 17767 (1.9%) | 12153 / 177670 (6.8%) | −195.5 | −193.0 | 0.27 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 789 / 17767 (4.4%) | 19371 / 177670 (10.9%) | −194.5 | −192.0 | 0.41 |
| ESR1 SRX20282939 | MCF-7 Breast | 400 / 17767 (2.3%) | 13334 / 177670 (7.5%) | −194.5 | −192.0 | 0.30 |
| FOS SRX4192879 | MCF 10A Breast | 402 / 17767 (2.3%) | 13308 / 177670 (7.5%) | −192.7 | −190.3 | 0.30 |
| FOXA1 SRX1161174 | MCF-7 Breast | 350 / 17767 (2.0%) | 12421 / 177670 (7.0%) | −192.6 | −190.1 | 0.28 |
| ESR1 SRX371470 | ZR-75-1 Breast | 313 / 17767 (1.8%) | 11776 / 177670 (6.6%) | −192.6 | −190.1 | 0.27 |
| ESR1 SRX194569 | MCF-7 Breast | 366 / 17767 (2.1%) | 12688 / 177670 (7.1%) | −192.3 | −189.9 | 0.29 |
| CEBPB SRX150632 | HeLa Uterus | 821 / 17767 (4.6%) | 19740 / 177670 (11.1%) | −191.9 | −189.5 | 0.42 |
| ARID1A SRX5089376 | MCF-7 Breast | 284 / 17767 (1.6%) | 11224 / 177670 (6.3%) | −191.3 | −188.8 | 0.25 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 277 / 17767 (1.6%) | 118 / 177670 (0.1%) | −190.9 | −188.4 | 23.47 |
| ESR1 SRX1531791 | MCF-7 Breast | 336 / 17767 (1.9%) | 12124 / 177670 (6.8%) | −190.8 | −188.3 | 0.28 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 891 / 17767 (5.0%) | 20704 / 177670 (11.7%) | −190.8 | −188.3 | 0.43 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1325 / 17767 (7.5%) | 26648 / 177670 (15.0%) | −190.4 | −187.9 | 0.50 |
| AR SRX1067071 | LHSAR Prostate | 709 / 17767 (4.0%) | 18032 / 177670 (10.1%) | −190.2 | −187.7 | 0.39 |
| ESR1 SRX371476 | MCF-7 Breast | 255 / 17767 (1.4%) | 10635 / 177670 (6.0%) | −189.4 | −187.0 | 0.24 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 861 / 17767 (4.8%) | 20194 / 177670 (11.4%) | −188.7 | −186.2 | 0.43 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 320 / 17767 (1.8%) | 11773 / 177670 (6.6%) | −188.6 | −186.1 | 0.27 |
| BRPF3 SRX796086 | RKO Digestive tract | 1505 / 17767 (8.5%) | 6089 / 177670 (3.4%) | −188.4 | −186.0 | 2.47 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 312 / 17767 (1.8%) | 11625 / 177670 (6.5%) | −188.2 | −185.7 | 0.27 |
| AR SRX10820653 | LNCAP Prostate | 318 / 17767 (1.8%) | 211 / 177670 (0.1%) | −187.8 | −185.4 | 15.07 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 317 / 17767 (1.8%) | 11691 / 177670 (6.6%) | −187.5 | −185.1 | 0.27 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 466 / 17767 (2.6%) | 14167 / 177670 (8.0%) | −187.0 | −184.6 | 0.33 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 627 / 17767 (3.5%) | 16670 / 177670 (9.4%) | −186.7 | −184.3 | 0.38 |
| ESR1 SRX371467 | MCF-7 Breast | 381 / 17767 (2.1%) | 12684 / 177670 (7.1%) | −184.4 | −182.0 | 0.30 |
| TP53 SRX396254 | Fibroblasts Others | 944 / 17767 (5.3%) | 2840 / 177670 (1.6%) | −184.1 | −181.7 | 3.32 |
| JUNB SRX8488089 | SUM 229PE Breast | 352 / 17767 (2.0%) | 12165 / 177670 (6.8%) | −183.5 | −181.1 | 0.29 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1448 / 17767 (8.1%) | 27971 / 177670 (15.7%) | −183.4 | −181.0 | 0.52 |
| FOXA1 SRX1787653 | MCF-7 Breast | 280 / 17767 (1.6%) | 10899 / 177670 (6.1%) | −183.2 | −180.8 | 0.26 |
| FOXA1 SRX100454 | T-47D Breast | 477 / 17767 (2.7%) | 14198 / 177670 (8.0%) | −182.6 | −180.2 | 0.34 |
| GATA3 SRX176864 | MCF-7 Breast | 256 / 17767 (1.4%) | 10444 / 177670 (5.9%) | −182.4 | −180.0 | 0.25 |
| FOXA1 SRX371480 | MCF-7 Breast | 235 / 17767 (1.3%) | 10047 / 177670 (5.7%) | −182.1 | −179.7 | 0.23 |
| RAC1 SRX10365541 | MCF-7 Breast | 173 / 17767 (1.0%) | 8850 / 177670 (5.0%) | −182.0 | −179.6 | 0.20 |
| ARID1A SRX5089379 | MCF-7 Breast | 345 / 17767 (1.9%) | 11994 / 177670 (6.8%) | −181.9 | −179.5 | 0.29 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 268 / 17767 (1.5%) | 10624 / 177670 (6.0%) | −181.2 | −178.8 | 0.25 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 395 / 17767 (2.2%) | 12802 / 177670 (7.2%) | −180.9 | −178.5 | 0.31 |
| AR SRX1067070 | LHSAR Prostate | 920 / 17767 (5.2%) | 20658 / 177670 (11.6%) | −179.0 | −176.7 | 0.45 |
| ESR1 SRX20282954 | MCF-7 Breast | 404 / 17767 (2.3%) | 12893 / 177670 (7.3%) | −179.0 | −176.6 | 0.31 |
| ESR1 SRX194572 | MCF-7 Breast | 223 / 17767 (1.3%) | 9728 / 177670 (5.5%) | −178.9 | −176.6 | 0.23 |
| GATA3 SRX5057632 | MCF-7 Breast | 224 / 17767 (1.3%) | 9738 / 177670 (5.5%) | −178.7 | −176.3 | 0.23 |
| ESR1 SRX20282972 | MCF-7 Breast | 414 / 17767 (2.3%) | 13031 / 177670 (7.3%) | −178.3 | −175.9 | 0.32 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1290 / 17767 (7.3%) | 25669 / 177670 (14.4%) | −178.2 | −175.9 | 0.50 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 657 / 17767 (3.7%) | 1475 / 177670 (0.8%) | −177.9 | −175.6 | 4.45 |
| YAP1 SRX5718140 | 293 Kidney | 646 / 17767 (3.6%) | 16630 / 177670 (9.4%) | −177.6 | −175.2 | 0.39 |
| STAT3 SRX2020842 | HCC70 Breast | 666 / 17767 (3.7%) | 16929 / 177670 (9.5%) | −177.5 | −175.2 | 0.39 |
| FOXA2 SRX3230382 | Hep G2 Liver | 504 / 17767 (2.8%) | 14440 / 177670 (8.1%) | −177.3 | −175.0 | 0.35 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 369 / 17767 (2.1%) | 12250 / 177670 (6.9%) | −177.3 | −174.9 | 0.30 |
| SREBF2 SRX5359048 | HCC70 Breast | 1758 / 17767 (9.9%) | 7969 / 177670 (4.5%) | −177.1 | −174.8 | 2.21 |
| JUN SRX4192884 | MCF 10A Breast | 302 / 17767 (1.7%) | 11063 / 177670 (6.2%) | −176.0 | −173.7 | 0.27 |
| TRP47 SRX4548329 | THP-1 Blood | 2672 / 17767 (15.0%) | 14591 / 177670 (8.2%) | −175.8 | −173.4 | 1.83 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 326 / 17767 (1.8%) | 11459 / 177670 (6.4%) | −175.3 | −173.0 | 0.28 |
| ING5 SRX286202 | RKO Digestive tract | 1356 / 17767 (7.6%) | 5378 / 177670 (3.0%) | −175.2 | −172.9 | 2.52 |
| JUN SRX17561461 | LPS141 Adipocyte | 553 / 17767 (3.1%) | 15129 / 177670 (8.5%) | −175.2 | −172.9 | 0.37 |
| ESR1 SRX371468 | MCF-7 Breast | 231 / 17767 (1.3%) | 9757 / 177670 (5.5%) | −175.0 | −172.7 | 0.24 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 348 / 17767 (2.0%) | 11813 / 177670 (6.6%) | −174.7 | −172.4 | 0.29 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 630 / 17767 (3.5%) | 16201 / 177670 (9.1%) | −172.5 | −170.1 | 0.39 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 348 / 17767 (2.0%) | 11734 / 177670 (6.6%) | −172.3 | −170.0 | 0.30 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1297 / 17767 (7.3%) | 25488 / 177670 (14.3%) | −171.9 | −169.6 | 0.51 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 342 / 17767 (1.9%) | 11613 / 177670 (6.5%) | −171.6 | −169.3 | 0.29 |
| JUNB SRX8488073 | SUM 229PE Breast | 726 / 17767 (4.1%) | 17590 / 177670 (9.9%) | −171.5 | −169.2 | 0.41 |
| ESR1 SRX10365536 | MCF-7 Breast | 185 / 17767 (1.0%) | 8779 / 177670 (4.9%) | −171.5 | −169.2 | 0.21 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 162 / 17767 (0.9%) | 8314 / 177670 (4.7%) | −171.0 | −168.7 | 0.19 |
| ESR1 SRX20282946 | MCF-7 Breast | 211 / 17767 (1.2%) | 9260 / 177670 (5.2%) | −170.9 | −168.7 | 0.23 |
| FOXA1 SRX11222441 | MCF-7 Breast | 282 / 17767 (1.6%) | 10547 / 177670 (5.9%) | −170.8 | −168.5 | 0.27 |
| FOXA1 SRX3923514 | MCF-7 Breast | 388 / 17767 (2.2%) | 12348 / 177670 (6.9%) | −170.6 | −168.3 | 0.31 |
| SMARCA2 SRX8119677 | MeT-5A Others | 636 / 17767 (3.6%) | 16216 / 177670 (9.1%) | −170.3 | −168.0 | 0.39 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 258 / 17767 (1.5%) | 10105 / 177670 (5.7%) | −170.3 | −168.0 | 0.26 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 293 / 17767 (1.6%) | 10714 / 177670 (6.0%) | −170.0 | −167.7 | 0.27 |
| GATA3 SRX6712581 | MCF-7 Breast | 301 / 17767 (1.7%) | 10843 / 177670 (6.1%) | −169.6 | −167.3 | 0.28 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 365 / 17767 (2.1%) | 11926 / 177670 (6.7%) | −169.4 | −167.1 | 0.31 |
| ESR1 SRX371477 | MCF-7 Breast | 175 / 17767 (1.0%) | 8505 / 177670 (4.8%) | −168.8 | −166.5 | 0.21 |
| ESR1 SRX20282973 | MCF-7 Breast | 460 / 17767 (2.6%) | 13453 / 177670 (7.6%) | −168.8 | −166.5 | 0.34 |
| EP300 SRX176885 | MCF-7 Breast | 177 / 17767 (1.0%) | 8540 / 177670 (4.8%) | −168.6 | −166.3 | 0.21 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 525 / 17767 (3.0%) | 978 / 177670 (0.6%) | −168.5 | −166.2 | 5.37 |
| FOXA1 SRX11222442 | MCF-7 Breast | 245 / 17767 (1.4%) | 9796 / 177670 (5.5%) | −167.9 | −165.6 | 0.25 |
| FOXA1 SRX11222437 | MCF-7 Breast | 266 / 17767 (1.5%) | 10167 / 177670 (5.7%) | −167.7 | −165.4 | 0.26 |
| NR2F2 SRX190293 | MCF-7 Breast | 400 / 17767 (2.3%) | 12442 / 177670 (7.0%) | −167.6 | −165.3 | 0.32 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1167 / 17767 (6.6%) | 4339 / 177670 (2.4%) | −167.5 | −165.2 | 2.69 |
| RAC1 SRX10365543 | MCF-7 Breast | 193 / 17767 (1.1%) | 8815 / 177670 (5.0%) | −167.5 | −165.2 | 0.22 |
| SMARCA4 SRX5212366 | Mel270 Others | 520 / 17767 (2.9%) | 14329 / 177670 (8.1%) | −167.0 | −164.7 | 0.36 |
| ESR1 SRX2943591 | MCF-7 Breast | 259 / 17767 (1.5%) | 10015 / 177670 (5.6%) | −166.9 | −164.6 | 0.26 |
| GATA3 SRX190194 | SK-N-SH Neural | 934 / 17767 (5.3%) | 20366 / 177670 (11.5%) | −166.8 | −164.6 | 0.46 |
| TEAD1 SRX3401272 | MCF-7 Breast | 277 / 17767 (1.6%) | 10322 / 177670 (5.8%) | −166.3 | −164.1 | 0.27 |
| FOXA1 SRX1787652 | MCF-7 Breast | 219 / 17767 (1.2%) | 9269 / 177670 (5.2%) | −166.2 | −164.0 | 0.24 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 355 / 17767 (2.0%) | 11646 / 177670 (6.6%) | −166.0 | −163.7 | 0.30 |
| TCF12 SRX190356 | SK-N-SH Neural | 1072 / 17767 (6.0%) | 22218 / 177670 (12.5%) | −165.9 | −163.6 | 0.48 |
| FOXA1 SRX3931043 | MCF-7 Breast | 393 / 17767 (2.2%) | 12268 / 177670 (6.9%) | −165.7 | −163.5 | 0.32 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 702 / 17767 (4.0%) | 1798 / 177670 (1.0%) | −165.6 | −163.3 | 3.90 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 416 / 17767 (2.3%) | 12637 / 177670 (7.1%) | −165.6 | −163.3 | 0.33 |
| JUNB SRX4192882 | MCF 10A Breast | 303 / 17767 (1.7%) | 10739 / 177670 (6.0%) | −165.2 | −163.0 | 0.28 |
| ESR1 SRX4367192 | MCF-7 Breast | 801 / 17767 (4.5%) | 18425 / 177670 (10.4%) | −165.2 | −162.9 | 0.43 |
| MITF SRX1555436 | 501A Epidermis | 1995 / 17767 (11.2%) | 9892 / 177670 (5.6%) | −165.1 | −162.8 | 2.02 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 329 / 17767 (1.9%) | 11169 / 177670 (6.3%) | −164.9 | −162.6 | 0.29 |
| ESR1 SRX10365535 | MCF-7 Breast | 309 / 17767 (1.7%) | 10822 / 177670 (6.1%) | −164.7 | −162.5 | 0.29 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 945 / 17767 (5.3%) | 20428 / 177670 (11.5%) | −164.6 | −162.4 | 0.46 |
| AR SRX10820651 | LNCAP Prostate | 331 / 17767 (1.9%) | 321 / 177670 (0.2%) | −164.2 | −162.0 | 10.31 |
| TLE3 SRX4815192 | MCF-7 Breast | 345 / 17767 (1.9%) | 11418 / 177670 (6.4%) | −164.1 | −161.9 | 0.30 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 844 / 17767 (4.8%) | 18992 / 177670 (10.7%) | −164.0 | −161.8 | 0.44 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 642 / 17767 (3.6%) | 1530 / 177670 (0.9%) | −163.6 | −161.4 | 4.20 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 776 / 17767 (4.4%) | 17997 / 177670 (10.1%) | −163.4 | −161.2 | 0.43 |
| ESR1 SRX20282955 | MCF-7 Breast | 414 / 17767 (2.3%) | 12530 / 177670 (7.1%) | −163.4 | −161.2 | 0.33 |
| MEAF6 DRX234811 | 293 Kidney | 1697 / 17767 (9.6%) | 7852 / 177670 (4.4%) | −163.3 | −161.1 | 2.16 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 1045 / 17767 (5.9%) | 21742 / 177670 (12.2%) | −163.3 | −161.1 | 0.48 |
| FOXA1 SRX028634 | MCF-7 Breast | 180 / 17767 (1.0%) | 8433 / 177670 (4.7%) | −163.1 | −160.9 | 0.21 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1759 / 17767 (9.9%) | 8299 / 177670 (4.7%) | −162.2 | −160.0 | 2.12 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1606 / 17767 (9.0%) | 7255 / 177670 (4.1%) | −162.2 | −160.0 | 2.21 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1851 / 17767 (10.4%) | 8947 / 177670 (5.0%) | −162.0 | −159.8 | 2.07 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1932 / 17767 (10.9%) | 9527 / 177670 (5.4%) | −161.7 | −159.5 | 2.03 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 302 / 17767 (1.7%) | 10587 / 177670 (6.0%) | −161.1 | −158.9 | 0.29 |
| FOXA1 SRX100506 | Hep G2 Liver | 533 / 17767 (3.0%) | 14313 / 177670 (8.1%) | −161.0 | −158.8 | 0.37 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 404 / 17767 (2.3%) | 12282 / 177670 (6.9%) | −160.9 | −158.7 | 0.33 |
| MEAF6 DRX300417 | 293 Kidney | 1560 / 17767 (8.8%) | 6972 / 177670 (3.9%) | −160.8 | −158.6 | 2.24 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1665 / 17767 (9.4%) | 7687 / 177670 (4.3%) | −160.8 | −158.6 | 2.17 |
| ESR1 SRX2881002 | MCF-7 Breast | 374 / 17767 (2.1%) | 11774 / 177670 (6.6%) | −160.4 | −158.2 | 0.32 |
| JUNB SRX10119386 | MCF 10A Breast | 354 / 17767 (2.0%) | 11433 / 177670 (6.4%) | −160.1 | −157.9 | 0.31 |
| ESR1 SRX330067 | MCF-7 Breast | 351 / 17767 (2.0%) | 11382 / 177670 (6.4%) | −160.0 | −157.8 | 0.31 |
| FOXA1 SRX1447317 | MCF-7 Breast | 247 / 17767 (1.4%) | 9583 / 177670 (5.4%) | −159.9 | −157.7 | 0.26 |
| FOXA1 SRX5323843 | MCF-7 Breast | 188 / 17767 (1.1%) | 8494 / 177670 (4.8%) | −159.9 | −157.7 | 0.22 |
| VGLL1 SRX24602130 | BT-20 Breast | 411 / 17767 (2.3%) | 12355 / 177670 (7.0%) | −159.7 | −157.5 | 0.33 |
| AR SRX9469988 | LAPC-4 Prostate | 525 / 17767 (3.0%) | 14135 / 177670 (8.0%) | −159.4 | −157.3 | 0.37 |
| FOXA1 SRX3923517 | MCF-7 Breast | 274 / 17767 (1.5%) | 10040 / 177670 (5.7%) | −159.2 | −157.0 | 0.27 |
| ESR1 SRX371474 | BT-474 Breast | 164 / 17767 (0.9%) | 8010 / 177670 (4.5%) | −159.1 | −157.0 | 0.20 |
| ESR1 SRX3110725 | MCF-7 Breast | 348 / 17767 (2.0%) | 11302 / 177670 (6.4%) | −159.1 | −156.9 | 0.31 |
| JUNB SRX8488074 | SUM 229PE Breast | 532 / 17767 (3.0%) | 14225 / 177670 (8.0%) | −159.0 | −156.8 | 0.37 |
| SOX13 SRX2636248 | Hep G2 Liver | 557 / 17767 (3.1%) | 14600 / 177670 (8.2%) | −158.7 | −156.6 | 0.38 |
| ESR1 SRX20282940 | MCF-7 Breast | 436 / 17767 (2.5%) | 12721 / 177670 (7.2%) | −158.7 | −156.6 | 0.34 |
| EP300 SRX1012648 | MCF-7 Breast | 171 / 17767 (1.0%) | 8126 / 177670 (4.6%) | −158.6 | −156.4 | 0.21 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 511 / 17767 (2.9%) | 13886 / 177670 (7.8%) | −158.5 | −156.4 | 0.37 |
| ESR1 SRX371475 | BT-474 Breast | 186 / 17767 (1.0%) | 8417 / 177670 (4.7%) | −158.5 | −156.4 | 0.22 |
| SMARCA4 SRX5212357 | Mel270 Others | 582 / 17767 (3.3%) | 14962 / 177670 (8.4%) | −158.3 | −156.1 | 0.39 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1189 / 17767 (6.7%) | 23451 / 177670 (13.2%) | −158.0 | −155.8 | 0.51 |
| BMI1 SRX7196721 | SF8628 Neural | 1737 / 17767 (9.8%) | 8245 / 177670 (4.6%) | −157.9 | −155.8 | 2.11 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 380 / 17767 (2.1%) | 11791 / 177670 (6.6%) | −157.9 | −155.7 | 0.32 |
| ESR1 SRX2881000 | MCF-7 Breast | 349 / 17767 (2.0%) | 11270 / 177670 (6.3%) | −157.7 | −155.5 | 0.31 |
| TP53 SRX19538272 | U2OS Bone | 558 / 17767 (3.1%) | 1199 / 177670 (0.7%) | −157.5 | −155.4 | 4.65 |
| ESR1 SRX10365532 | MCF-7 Breast | 205 / 17767 (1.2%) | 8742 / 177670 (4.9%) | −157.5 | −155.4 | 0.23 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 798 / 17767 (4.5%) | 2377 / 177670 (1.3%) | −157.2 | −155.1 | 3.36 |
| STAT5B SRX831881 | CD8+ T cells Blood | 254 / 17767 (1.4%) | 150 / 177670 (0.1%) | −157.0 | −154.8 | 16.93 |
| SMARCA4 SRX5212362 | Mel270 Others | 700 / 17767 (3.9%) | 16646 / 177670 (9.4%) | −156.9 | −154.7 | 0.42 |
| FOXA1 SRX3931054 | MCF-7 Breast | 376 / 17767 (2.1%) | 11682 / 177670 (6.6%) | −156.7 | −154.6 | 0.32 |
| STAT3 SRX150630 | MCF 10A Breast | 368 / 17767 (2.1%) | 11554 / 177670 (6.5%) | −156.7 | −154.6 | 0.32 |
| FOXA1 SRX1787651 | MCF-7 Breast | 216 / 17767 (1.2%) | 8922 / 177670 (5.0%) | −156.7 | −154.6 | 0.24 |
| FOXA2 SRX100448 | Hep G2 Liver | 447 / 17767 (2.5%) | 12814 / 177670 (7.2%) | −156.4 | −154.2 | 0.35 |
| STAT3 SRX150479 | MCF 10A Breast | 373 / 17767 (2.1%) | 11620 / 177670 (6.5%) | −156.4 | −154.2 | 0.32 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 363 / 17767 (2.0%) | 11451 / 177670 (6.4%) | −156.1 | −154.0 | 0.32 |
| ARID5B SRX3230377 | Hep G2 Liver | 1014 / 17767 (5.7%) | 21017 / 177670 (11.8%) | −156.0 | −153.9 | 0.48 |
| PGR SRX1012655 | MCF-7 Breast | 242 / 17767 (1.4%) | 9366 / 177670 (5.3%) | −155.8 | −153.6 | 0.26 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 796 / 17767 (4.5%) | 17965 / 177670 (10.1%) | −155.3 | −153.2 | 0.44 |
| FOS SRX3322636 | MCF-7 Breast | 256 / 17767 (1.4%) | 9598 / 177670 (5.4%) | −155.3 | −153.2 | 0.27 |
| JUND SRX150408 | HeLa Uterus | 348 / 17767 (2.0%) | 11171 / 177670 (6.3%) | −155.2 | −153.0 | 0.31 |
| GATAD2A SRX2636506 | Hep G2 Liver | 523 / 17767 (2.9%) | 13946 / 177670 (7.8%) | −155.1 | −153.0 | 0.38 |
| Epitope tags DRX443510 | 293 Kidney | 1460 / 17767 (8.2%) | 6426 / 177670 (3.6%) | −154.9 | −152.8 | 2.27 |
| FOXA1 SRX1161203 | T-47D Breast | 281 / 17767 (1.6%) | 10013 / 177670 (5.6%) | −154.6 | −152.5 | 0.28 |
| FOXA1 SRX3923516 | MCF-7 Breast | 287 / 17767 (1.6%) | 10105 / 177670 (5.7%) | −154.2 | −152.1 | 0.28 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 185 / 17767 (1.0%) | 8262 / 177670 (4.7%) | −154.1 | −152.0 | 0.22 |
| FOXA1 SRX11222438 | MCF-7 Breast | 207 / 17767 (1.2%) | 8667 / 177670 (4.9%) | −153.8 | −151.7 | 0.24 |
| LEO1 SRX1873456 | SEM Blood | 1455 / 17767 (8.2%) | 6433 / 177670 (3.6%) | −152.9 | −150.8 | 2.26 |
| ESR1 SRX1531796 | MCF-7 Breast | 207 / 17767 (1.2%) | 8641 / 177670 (4.9%) | −152.9 | −150.8 | 0.24 |
| FOXA1 SRX3931055 | MCF-7 Breast | 345 / 17767 (1.9%) | 11036 / 177670 (6.2%) | −152.6 | −150.5 | 0.31 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 281 / 17767 (1.6%) | 9945 / 177670 (5.6%) | −152.4 | −150.3 | 0.28 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 378 / 17767 (2.1%) | 11564 / 177670 (6.5%) | −152.3 | −150.2 | 0.33 |
| ESR1 SRX330070 | MCF-7 Breast | 201 / 17767 (1.1%) | 8501 / 177670 (4.8%) | −152.0 | −149.9 | 0.24 |
| ARID1A SRX5089391 | MCF-7 Breast | 212 / 17767 (1.2%) | 8702 / 177670 (4.9%) | −151.9 | −149.8 | 0.24 |
| ESR1 SRX20282953 | MCF-7 Breast | 331 / 17767 (1.9%) | 10780 / 177670 (6.1%) | −151.9 | −149.8 | 0.31 |
| FOXA1 SRX15430999 | T-47D Breast | 450 / 17767 (2.5%) | 12701 / 177670 (7.1%) | −151.8 | −149.7 | 0.35 |
| JUN SRX883584 | MDA-MB-231 Breast | 652 / 17767 (3.7%) | 15736 / 177670 (8.9%) | −151.4 | −149.3 | 0.41 |
| ESR1 SRX20282971 | MCF-7 Breast | 408 / 17767 (2.3%) | 12004 / 177670 (6.8%) | −151.0 | −148.9 | 0.34 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 812 / 17767 (4.6%) | 18018 / 177670 (10.1%) | −151.0 | −148.9 | 0.45 |
| FOXA1 SRX1787655 | MCF-7 Breast | 195 / 17767 (1.1%) | 8356 / 177670 (4.7%) | −151.0 | −148.9 | 0.23 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 306 / 17767 (1.7%) | 10320 / 177670 (5.8%) | −150.8 | −148.7 | 0.30 |
| STAT3 SRX150536 | MCF 10A Breast | 461 / 17767 (2.6%) | 12834 / 177670 (7.2%) | −150.8 | −148.7 | 0.36 |
| GATA3 SRX5457550 | MCF-7 Breast | 461 / 17767 (2.6%) | 12831 / 177670 (7.2%) | −150.6 | −148.5 | 0.36 |
| EP300 SRX2194266 | SUM 159PT Breast | 717 / 17767 (4.0%) | 16645 / 177670 (9.4%) | −150.5 | −148.4 | 0.43 |
| ESR1 SRX2943589 | MCF-7 Breast | 199 / 17767 (1.1%) | 8420 / 177670 (4.7%) | −150.5 | −148.4 | 0.24 |
| ESR1 SRX4451213 | MCF-7 Breast | 411 / 17767 (2.3%) | 12034 / 177670 (6.8%) | −150.5 | −148.4 | 0.34 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1927 / 17767 (10.8%) | 9773 / 177670 (5.5%) | −150.4 | −148.4 | 1.97 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1311 / 17767 (7.4%) | 24698 / 177670 (13.9%) | −150.0 | −147.9 | 0.53 |
| FOXA1 SRX028635 | MCF-7 Breast | 200 / 17767 (1.1%) | 8410 / 177670 (4.7%) | −149.7 | −147.6 | 0.24 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 941 / 17767 (5.3%) | 19746 / 177670 (11.1%) | −149.6 | −147.5 | 0.48 |
| FOXA1 SRX3923518 | MCF-7 Breast | 282 / 17767 (1.6%) | 9854 / 177670 (5.5%) | −149.1 | −147.0 | 0.29 |
| ESR1 SRX1012632 | MCF-7 Breast | 192 / 17767 (1.1%) | 8242 / 177670 (4.6%) | −148.9 | −146.9 | 0.23 |
| AR SRX1067066 | LHSAR Prostate | 871 / 17767 (4.9%) | 18756 / 177670 (10.6%) | −148.9 | −146.8 | 0.46 |
| SMARCA4 SRX5212371 | Mel270 Others | 592 / 17767 (3.3%) | 14755 / 177670 (8.3%) | −148.9 | −146.8 | 0.40 |
| CEBPA SRX2630241 | Hep G2 Liver | 507 / 17767 (2.9%) | 13475 / 177670 (7.6%) | −148.8 | −146.7 | 0.38 |
| ARID1A SRX5089382 | MCF-7 Breast | 284 / 17767 (1.6%) | 9878 / 177670 (5.6%) | −148.7 | −146.7 | 0.29 |
| ARID1A SRX5089385 | MCF-7 Breast | 301 / 17767 (1.7%) | 10163 / 177670 (5.7%) | −148.6 | −146.5 | 0.30 |
| EP300 SRX150579 | HeLa Uterus | 267 / 17767 (1.5%) | 9579 / 177670 (5.4%) | −148.5 | −146.5 | 0.28 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 342 / 17767 (1.9%) | 10848 / 177670 (6.1%) | −148.5 | −146.4 | 0.32 |
| AR SRX1067067 | LHSAR Prostate | 699 / 17767 (3.9%) | 16305 / 177670 (9.2%) | −148.4 | −146.4 | 0.43 |
| JUND SRX092301 | K-562 Blood | 539 / 17767 (3.0%) | 13946 / 177670 (7.8%) | −148.4 | −146.3 | 0.39 |
| NKX2-1 SRX2164786 | A549 Lung | 691 / 17767 (3.9%) | 16175 / 177670 (9.1%) | −148.1 | −146.0 | 0.43 |
| ESR1 SRX3123829 | MCF-7 Breast | 229 / 17767 (1.3%) | 8889 / 177670 (5.0%) | −148.0 | −146.0 | 0.26 |
| ESR1 SRX1012629 | MCF-7 Breast | 251 / 17767 (1.4%) | 9280 / 177670 (5.2%) | −148.0 | −145.9 | 0.27 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 386 / 17767 (2.2%) | 11544 / 177670 (6.5%) | −147.9 | −145.9 | 0.33 |
| ESR1 SRX10365533 | MCF-7 Breast | 190 / 17767 (1.1%) | 8170 / 177670 (4.6%) | −147.9 | −145.9 | 0.23 |
| RELA SRX5938177 | FaDu Others | 379 / 17767 (2.1%) | 11433 / 177670 (6.4%) | −147.9 | −145.8 | 0.33 |
| EP300 SRX1012644 | MCF-7 Breast | 174 / 17767 (1.0%) | 7857 / 177670 (4.4%) | −147.5 | −145.4 | 0.22 |
| Epitope tags SRX10549778 | K-562 Blood | 1103 / 17767 (6.2%) | 4275 / 177670 (2.4%) | −147.4 | −145.4 | 2.58 |
| NANOG SRX10445309 | Neural crest cells Neural | 216 / 17767 (1.2%) | 8635 / 177670 (4.9%) | −147.3 | −145.3 | 0.25 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 598 / 17767 (3.4%) | 14789 / 177670 (8.3%) | −147.3 | −145.3 | 0.40 |
| ESR1 SRX5323873 | MCF-7 Breast | 510 / 17767 (2.9%) | 13447 / 177670 (7.6%) | −146.9 | −144.8 | 0.38 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 482 / 17767 (2.7%) | 12991 / 177670 (7.3%) | −146.1 | −144.1 | 0.37 |
| FOXA1 SRX3923519 | MCF-7 Breast | 255 / 17767 (1.4%) | 9290 / 177670 (5.2%) | −146.1 | −144.0 | 0.27 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 393 / 17767 (2.2%) | 11591 / 177670 (6.5%) | −146.0 | −144.0 | 0.34 |
| ARID5B SRX10475139 | Hep G2 Liver | 463 / 17767 (2.6%) | 12688 / 177670 (7.1%) | −145.9 | −143.8 | 0.36 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 1195 / 17767 (6.7%) | 22996 / 177670 (12.9%) | −145.9 | −143.8 | 0.52 |
| ESR1 SRX330069 | MCF-7 Breast | 253 / 17767 (1.4%) | 9238 / 177670 (5.2%) | −145.6 | −143.6 | 0.27 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 393 / 17767 (2.2%) | 11575 / 177670 (6.5%) | −145.6 | −143.6 | 0.34 |
| FOXA1 SRX6878603 | LNCAP Prostate | 465 / 17767 (2.6%) | 12705 / 177670 (7.2%) | −145.5 | −143.5 | 0.37 |
| AR SRX9109110 | MDA-MB-453 Breast | 777 / 17767 (4.4%) | 17294 / 177670 (9.7%) | −145.4 | −143.3 | 0.45 |
| ESR1 SRX8537722 | MCF-7 Breast | 390 / 17767 (2.2%) | 11518 / 177670 (6.5%) | −145.3 | −143.3 | 0.34 |
| FOSL2 SRX190204 | A549 Lung | 418 / 17767 (2.4%) | 11962 / 177670 (6.7%) | −145.2 | −143.1 | 0.35 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 445 / 17767 (2.5%) | 12377 / 177670 (7.0%) | −145.0 | −143.0 | 0.36 |
| ZEB1 SRX13298925 | MCF-7 Breast | 250 / 17767 (1.4%) | 9168 / 177670 (5.2%) | −145.0 | −143.0 | 0.27 |
| RUNX1 SRX2014504 | Jurkat Blood | 2401 / 17767 (13.5%) | 13450 / 177670 (7.6%) | −144.9 | −142.9 | 1.79 |
| ESR1 SRX10365558 | MCF-7 Breast | 279 / 17767 (1.6%) | 9662 / 177670 (5.4%) | −144.8 | −142.8 | 0.29 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 268 / 17767 (1.5%) | 9468 / 177670 (5.3%) | −144.6 | −142.6 | 0.28 |
| CEBPB SRX190345 | MCF-7 Breast | 320 / 17767 (1.8%) | 10329 / 177670 (5.8%) | −144.0 | −141.9 | 0.31 |
| ESR1 SRX1469949 | MCF-7 Breast | 235 / 17767 (1.3%) | 8865 / 177670 (5.0%) | −143.9 | −141.9 | 0.27 |
| ESR1 SRX20282938 | MCF-7 Breast | 339 / 17767 (1.9%) | 10638 / 177670 (6.0%) | −143.8 | −141.8 | 0.32 |
| EP300 SRX2194265 | SUM 159PT Breast | 664 / 17767 (3.7%) | 15605 / 177670 (8.8%) | −143.5 | −141.5 | 0.43 |
| FOXA1 SRX5203303 | MCF-7 Breast | 135 / 17767 (0.8%) | 6975 / 177670 (3.9%) | −143.4 | −141.4 | 0.19 |
| ESR1 SRX330068 | MCF-7 Breast | 190 / 17767 (1.1%) | 8035 / 177670 (4.5%) | −143.4 | −141.4 | 0.24 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 441 / 17767 (2.5%) | 12253 / 177670 (6.9%) | −143.3 | −141.3 | 0.36 |
| EP300 SRX1012643 | MCF-7 Breast | 140 / 17767 (0.8%) | 7059 / 177670 (4.0%) | −143.0 | −141.0 | 0.20 |
| ESR1 SRX20282959 | MCF-7 Breast | 167 / 17767 (0.9%) | 7587 / 177670 (4.3%) | −143.0 | −141.0 | 0.22 |
| FOS SRX3322637 | MCF-7 Breast | 223 / 17767 (1.3%) | 8622 / 177670 (4.9%) | −143.0 | −141.0 | 0.26 |
| DAXX SRX1021630 | PC-3 Prostate | 432 / 17767 (2.4%) | 12099 / 177670 (6.8%) | −142.9 | −140.9 | 0.36 |
| NR3C1 SRX17639412 | A549 Lung | 474 / 17767 (2.7%) | 12750 / 177670 (7.2%) | −142.8 | −140.8 | 0.37 |
| FOXA1 SRX1961158 | T-47D Breast | 418 / 17767 (2.4%) | 11876 / 177670 (6.7%) | −142.8 | −140.8 | 0.35 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1228 / 17767 (6.9%) | 5148 / 177670 (2.9%) | −142.6 | −140.6 | 2.39 |
| WWTR1 SRX10119367 | MCF 10A Breast | 496 / 17767 (2.8%) | 13071 / 177670 (7.4%) | −142.5 | −140.5 | 0.38 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 2044 / 17767 (11.5%) | 10842 / 177670 (6.1%) | −142.4 | −140.4 | 1.89 |
| FOXA1 SRX3923515 | MCF-7 Breast | 234 / 17767 (1.3%) | 8797 / 177670 (5.0%) | −142.2 | −140.2 | 0.27 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 626 / 17767 (3.5%) | 14999 / 177670 (8.4%) | −142.1 | −140.1 | 0.42 |
| FOXA1 SRX100477 | Hep G2 Liver | 492 / 17767 (2.8%) | 12998 / 177670 (7.3%) | −142.0 | −140.0 | 0.38 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 557 / 17767 (3.1%) | 13978 / 177670 (7.9%) | −142.0 | −140.0 | 0.40 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1212 / 17767 (6.8%) | 23041 / 177670 (13.0%) | −142.0 | −140.0 | 0.53 |
| ESR1 SRX2912055 | MCF-7 Breast | 157 / 17767 (0.9%) | 7363 / 177670 (4.1%) | −142.0 | −140.0 | 0.21 |
| CDK9 SRX7366783 | MCF-7 Breast | 239 / 17767 (1.3%) | 157 / 177670 (0.1%) | −141.8 | −139.8 | 15.22 |
| PROX1 SRX3230397 | Hep G2 Liver | 310 / 17767 (1.7%) | 10076 / 177670 (5.7%) | −141.4 | −139.4 | 0.31 |
| EP300 SRX176883 | MCF-7 Breast | 190 / 17767 (1.1%) | 7968 / 177670 (4.5%) | −141.3 | −139.4 | 0.24 |
| SP1 SRX190358 | HCT 116 Digestive tract | 655 / 17767 (3.7%) | 15390 / 177670 (8.7%) | −141.3 | −139.3 | 0.43 |
| MECOM SRX23677885 | HNT-34 Blood | 1729 / 17767 (9.7%) | 8586 / 177670 (4.8%) | −141.2 | −139.2 | 2.01 |
| FOXA1 SRX5323829 | T-47D Breast | 237 / 17767 (1.3%) | 8818 / 177670 (5.0%) | −141.2 | −139.2 | 0.27 |
| CEBPA SRX4705113 | MOLM-13 Blood | 975 / 17767 (5.5%) | 19852 / 177670 (11.2%) | −141.1 | −139.1 | 0.49 |
| SS18 SRX3468047 | Fibroblasts Others | 1069 / 17767 (6.0%) | 21111 / 177670 (11.9%) | −141.1 | −139.1 | 0.51 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1797 / 17767 (10.1%) | 9080 / 177670 (5.1%) | −141.0 | −139.0 | 1.98 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 155 / 17767 (0.9%) | 7293 / 177670 (4.1%) | −140.9 | −139.0 | 0.21 |
| ESR1 SRX1012633 | MCF-7 Breast | 215 / 17767 (1.2%) | 8413 / 177670 (4.7%) | −140.8 | −138.8 | 0.26 |
| MECOM SRX23677884 | HNT-34 Blood | 1704 / 17767 (9.6%) | 8420 / 177670 (4.7%) | −140.8 | −138.8 | 2.02 |
| ARID1A SRX5089388 | MCF-7 Breast | 209 / 17767 (1.2%) | 8300 / 177670 (4.7%) | −140.7 | −138.8 | 0.25 |
| BMI1 SRX644729 | 293 Kidney | 226 / 17767 (1.3%) | 131 / 177670 (0.1%) | −140.7 | −138.7 | 17.25 |
| GATA3 SRX100559 | T-47D Breast | 469 / 17767 (2.6%) | 12595 / 177670 (7.1%) | −140.7 | −138.7 | 0.37 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 442 / 17767 (2.5%) | 12178 / 177670 (6.9%) | −140.7 | −138.7 | 0.36 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 349 / 17767 (2.0%) | 10697 / 177670 (6.0%) | −140.6 | −138.7 | 0.33 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 873 / 17767 (4.9%) | 3011 / 177670 (1.7%) | −140.3 | −138.3 | 2.90 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1867 / 17767 (10.5%) | 9618 / 177670 (5.4%) | −139.7 | −137.7 | 1.94 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 326 / 17767 (1.8%) | 10285 / 177670 (5.8%) | −139.7 | −137.7 | 0.32 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 787 / 17767 (4.4%) | 17202 / 177670 (9.7%) | −139.6 | −137.7 | 0.46 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 756 / 17767 (4.3%) | 16768 / 177670 (9.4%) | −139.6 | −137.7 | 0.45 |
| FOXA1 SRX5323830 | T-47D Breast | 250 / 17767 (1.4%) | 8986 / 177670 (5.1%) | −139.4 | −137.4 | 0.28 |
| VGLL1 SRX18013277 | FULVR Breast | 179 / 17767 (1.0%) | 7707 / 177670 (4.3%) | −139.3 | −137.4 | 0.23 |
| FOXA1 SRX5323845 | MCF-7 Breast | 150 / 17767 (0.8%) | 7146 / 177670 (4.0%) | −139.1 | −137.2 | 0.21 |
| ESR1 SRX10365534 | MCF-7 Breast | 118 / 17767 (0.7%) | 6500 / 177670 (3.7%) | −139.1 | −137.2 | 0.18 |
| ESR1 SRX5323871 | MCF-7 Breast | 472 / 17767 (2.7%) | 12579 / 177670 (7.1%) | −139.0 | −137.1 | 0.38 |
| ESR1 SRX4451212 | MCF-7 Breast | 404 / 17767 (2.3%) | 11519 / 177670 (6.5%) | −138.9 | −137.0 | 0.35 |
| YAP1 SRX10119364 | MCF 10A Breast | 366 / 17767 (2.1%) | 10911 / 177670 (6.1%) | −138.9 | −137.0 | 0.34 |
| JUNB SRX10119383 | MCF 10A Breast | 299 / 17767 (1.7%) | 9804 / 177670 (5.5%) | −138.8 | −136.8 | 0.30 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 621 / 17767 (3.5%) | 14789 / 177670 (8.3%) | −138.6 | −136.7 | 0.42 |
| FOXA1 SRX13814018 | 5637 Others | 270 / 17767 (1.5%) | 9306 / 177670 (5.2%) | −138.6 | −136.6 | 0.29 |
| FOXA1 SRX3931033 | MCF-7 Breast | 276 / 17767 (1.6%) | 9409 / 177670 (5.3%) | −138.5 | −136.6 | 0.29 |
| GATAD2A SRX2636507 | Hep G2 Liver | 468 / 17767 (2.6%) | 12493 / 177670 (7.0%) | −138.3 | −136.4 | 0.37 |
| FOXA1 SRX5323846 | MCF-7 Breast | 156 / 17767 (0.9%) | 7235 / 177670 (4.1%) | −138.2 | −136.3 | 0.22 |
| NR3C1 SRX19024866 | MCF-7 Breast | 140 / 17767 (0.8%) | 6915 / 177670 (3.9%) | −138.1 | −136.2 | 0.20 |
| ESR1 SRX1012630 | MCF-7 Breast | 159 / 17767 (0.9%) | 7282 / 177670 (4.1%) | −138.0 | −136.0 | 0.22 |
| AR SRX9109113 | MDA-MB-453 Breast | 819 / 17767 (4.6%) | 17573 / 177670 (9.9%) | −137.9 | −135.9 | 0.47 |
| FOXA1 SRX190181 | A549 Lung | 320 / 17767 (1.8%) | 10118 / 177670 (5.7%) | −137.7 | −135.8 | 0.32 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 290 / 17767 (1.6%) | 9615 / 177670 (5.4%) | −137.6 | −135.7 | 0.30 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 288 / 17767 (1.6%) | 9580 / 177670 (5.4%) | −137.6 | −135.6 | 0.30 |
| ESR1 SRX792933 | LY2 Breast | 350 / 17767 (2.0%) | 10602 / 177670 (6.0%) | −137.5 | −135.6 | 0.33 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 151 / 17767 (0.8%) | 7102 / 177670 (4.0%) | −137.1 | −135.1 | 0.21 |
| FOXA1 SRX5203294 | MCF-7 Breast | 117 / 17767 (0.7%) | 6411 / 177670 (3.6%) | −136.8 | −134.8 | 0.18 |
| FOXA1 SRX5203307 | MCF-7 Breast | 121 / 17767 (0.7%) | 6494 / 177670 (3.7%) | −136.7 | −134.7 | 0.19 |
| ESR1 SRX5323878 | MCF-7 Breast | 436 / 17767 (2.5%) | 11928 / 177670 (6.7%) | −136.3 | −134.4 | 0.37 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 763 / 17767 (4.3%) | 16717 / 177670 (9.4%) | −136.1 | −134.2 | 0.46 |
| NR3C1 SRX8520802 | HCC1187 Breast | 325 / 17767 (1.8%) | 10144 / 177670 (5.7%) | −136.0 | −134.0 | 0.32 |
| FOXA1 SRX1447316 | MCF-7 Breast | 185 / 17767 (1.0%) | 7711 / 177670 (4.3%) | −135.9 | −134.0 | 0.24 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 516 / 17767 (2.9%) | 13129 / 177670 (7.4%) | −135.8 | −133.9 | 0.39 |
| FOXA1 SRX1161205 | T-47D Breast | 227 / 17767 (1.3%) | 8467 / 177670 (4.8%) | −135.8 | −133.8 | 0.27 |
| HMG20A SRX2630163 | Hep G2 Liver | 249 / 17767 (1.4%) | 8852 / 177670 (5.0%) | −135.7 | −133.8 | 0.28 |
| EP300 SRX100544 | Hep G2 Liver | 335 / 17767 (1.9%) | 10298 / 177670 (5.8%) | −135.7 | −133.7 | 0.33 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 329 / 17767 (1.9%) | 10198 / 177670 (5.7%) | −135.6 | −133.7 | 0.32 |
| EP300 SRX100540 | SK-N-SH Neural | 633 / 17767 (3.6%) | 14846 / 177670 (8.4%) | −135.6 | −133.7 | 0.43 |
| FOXA1 SRX1961157 | T-47D Breast | 477 / 17767 (2.7%) | 12531 / 177670 (7.1%) | −135.6 | −133.6 | 0.38 |
| CDK9 SRX7366781 | MCF-7 Breast | 227 / 17767 (1.3%) | 147 / 177670 (0.1%) | −135.5 | −133.6 | 15.44 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 157 / 17767 (0.9%) | 7166 / 177670 (4.0%) | −135.3 | −133.3 | 0.22 |
| SMARCA4 SRX5982340 | A549 Lung | 176 / 17767 (1.0%) | 7517 / 177670 (4.2%) | −135.0 | −133.0 | 0.23 |
| ESR1 SRX5323877 | MCF-7 Breast | 341 / 17767 (1.9%) | 10366 / 177670 (5.8%) | −134.9 | −133.0 | 0.33 |
| ESR1 SRX2513517 | MCF-7 Breast | 295 / 17767 (1.7%) | 9608 / 177670 (5.4%) | −134.9 | −132.9 | 0.31 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1498 / 17767 (8.4%) | 26367 / 177670 (14.8%) | −134.7 | −132.8 | 0.57 |
| SSRP1 SRX3436567 | HT-1080 Bone | 373 / 17767 (2.1%) | 600 / 177670 (0.3%) | −134.6 | −132.7 | 6.22 |
| SOX5 SRX2636544 | Hep G2 Liver | 442 / 17767 (2.5%) | 11953 / 177670 (6.7%) | −134.5 | −132.6 | 0.37 |
| CEBPB SRX2194250 | SUM 159PT Breast | 538 / 17767 (3.0%) | 13403 / 177670 (7.5%) | −134.4 | −132.5 | 0.40 |
| FOXA1 SRX3931056 | MCF-7 Breast | 260 / 17767 (1.5%) | 8991 / 177670 (5.1%) | −134.1 | −132.2 | 0.29 |
| ZEB1 SRX13298924 | MCF-7 Breast | 207 / 17767 (1.2%) | 8056 / 177670 (4.5%) | −134.1 | −132.2 | 0.26 |
| FOXL2 SRX6957431 | KGN Gonad | 1000 / 17767 (5.6%) | 19882 / 177670 (11.2%) | −134.1 | −132.2 | 0.50 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 117 / 17767 (0.7%) | 6335 / 177670 (3.6%) | −134.1 | −132.2 | 0.18 |
| TFAP2C SRX018833 | MCF-7 Breast | 397 / 17767 (2.2%) | 11235 / 177670 (6.3%) | −134.1 | −132.2 | 0.35 |
| FOXA1 SRX1161207 | T-47D Breast | 175 / 17767 (1.0%) | 7467 / 177670 (4.2%) | −134.0 | −132.1 | 0.23 |
| FOXA1 SRX1787654 | MCF-7 Breast | 157 / 17767 (0.9%) | 7119 / 177670 (4.0%) | −133.8 | −131.9 | 0.22 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 698 / 17767 (3.9%) | 15705 / 177670 (8.8%) | −133.7 | −131.8 | 0.44 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 119 / 17767 (0.7%) | 6366 / 177670 (3.6%) | −133.7 | −131.8 | 0.19 |
| TFAP2C SRX128099 | MCF-7 Breast | 398 / 17767 (2.2%) | 11238 / 177670 (6.3%) | −133.6 | −131.7 | 0.35 |
| ESR1 SRX1469951 | MCF-7 Breast | 228 / 17767 (1.3%) | 8416 / 177670 (4.7%) | −133.5 | −131.6 | 0.27 |
| MECOM SRX23677897 | HNT-34 Blood | 2005 / 17767 (11.3%) | 10801 / 177670 (6.1%) | −133.5 | −131.6 | 1.86 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 280 / 17767 (1.6%) | 9310 / 177670 (5.2%) | −133.5 | −131.6 | 0.30 |
| MECOM SRX23677896 | HNT-34 Blood | 2073 / 17767 (11.7%) | 11310 / 177670 (6.4%) | −133.5 | −131.6 | 1.83 |
| FOSL2 SRX190296 | SK-N-SH Neural | 593 / 17767 (3.3%) | 14176 / 177670 (8.0%) | −133.4 | −131.5 | 0.42 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 302 / 17767 (1.7%) | 9671 / 177670 (5.4%) | −133.3 | −131.4 | 0.31 |
| ESR1 SRX11120903 | MCF-7 Breast | 383 / 17767 (2.2%) | 10982 / 177670 (6.2%) | −133.2 | −131.3 | 0.35 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 370 / 17767 (2.1%) | 10772 / 177670 (6.1%) | −133.1 | −131.2 | 0.34 |
| PRRX1 SRX15235713 | Hs 578T Breast | 549 / 17767 (3.1%) | 13504 / 177670 (7.6%) | −132.7 | −130.8 | 0.41 |
| JUND SRX190357 | SK-N-SH Neural | 567 / 17767 (3.2%) | 13769 / 177670 (7.7%) | −132.7 | −130.8 | 0.41 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 779 / 17767 (4.4%) | 16793 / 177670 (9.5%) | −132.4 | −130.5 | 0.46 |
| SP1 SRX190269 | A549 Lung | 650 / 17767 (3.7%) | 14958 / 177670 (8.4%) | −132.3 | −130.4 | 0.43 |
| FOXA1 SRX3931032 | MCF-7 Breast | 261 / 17767 (1.5%) | 8947 / 177670 (5.0%) | −132.3 | −130.4 | 0.29 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 575 / 17767 (3.2%) | 13868 / 177670 (7.8%) | −132.2 | −130.4 | 0.41 |
| MethylCap SRX014767 | NB-4 Blood | 1670 / 17767 (9.4%) | 8393 / 177670 (4.7%) | −132.1 | −130.3 | 1.99 |
| RNF2 SRX18954719 | SCC-25 Others | 596 / 17767 (3.4%) | 14172 / 177670 (8.0%) | −132.1 | −130.2 | 0.42 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 254 / 17767 (1.4%) | 8814 / 177670 (5.0%) | −132.0 | −130.1 | 0.29 |
| ESR1 SRX8537723 | MCF-7 Breast | 363 / 17767 (2.0%) | 10613 / 177670 (6.0%) | −131.8 | −130.0 | 0.34 |
| WWTR1 SRX10119378 | MCF 10A Breast | 479 / 17767 (2.7%) | 12419 / 177670 (7.0%) | −131.7 | −129.9 | 0.39 |
| NR3C1 SRX1161167 | MCF-7 Breast | 108 / 17767 (0.6%) | 6084 / 177670 (3.4%) | −131.7 | −129.9 | 0.18 |
| MAU2 SRX11120893 | MCF-7 Breast | 174 / 17767 (1.0%) | 7371 / 177670 (4.1%) | −131.6 | −129.7 | 0.24 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 185 / 17767 (1.0%) | 7571 / 177670 (4.3%) | −131.3 | −129.5 | 0.24 |
| EP300 SRX2671820 | iPS cells Pluripotent stem cell | 97 / 17767 (0.5%) | 5830 / 177670 (3.3%) | −131.0 | −129.2 | 0.17 |
| ESR1 SRX5534831 | MCF-7 Breast | 346 / 17767 (1.9%) | 10317 / 177670 (5.8%) | −131.0 | −129.2 | 0.34 |
| NR3C1 SRX19024870 | MCF-7 Breast | 142 / 17767 (0.8%) | 6747 / 177670 (3.8%) | −131.0 | −129.1 | 0.21 |
| NCOA3 SRX4663589 | MCF-7 Breast | 121 / 17767 (0.7%) | 6326 / 177670 (3.6%) | −131.0 | −129.1 | 0.19 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1733 / 17767 (9.8%) | 8882 / 177670 (5.0%) | −130.8 | −128.9 | 1.95 |
| ESR1 SRX2513520 | MCF-7 Breast | 283 / 17767 (1.6%) | 9270 / 177670 (5.2%) | −130.7 | −128.9 | 0.31 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 295 / 17767 (1.7%) | 9463 / 177670 (5.3%) | −130.6 | −128.7 | 0.31 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 638 / 17767 (3.6%) | 14713 / 177670 (8.3%) | −130.4 | −128.5 | 0.43 |
| CBX3 SRX190214 | HCT 116 Digestive tract | 763 / 17767 (4.3%) | 16482 / 177670 (9.3%) | −130.3 | −128.5 | 0.46 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 140 / 17767 (0.8%) | 6685 / 177670 (3.8%) | −130.3 | −128.4 | 0.21 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 206 / 17767 (1.2%) | 7919 / 177670 (4.5%) | −130.3 | −128.4 | 0.26 |
| FOXA2 SRX10475773 | Hep G2 Liver | 550 / 17767 (3.1%) | 13424 / 177670 (7.6%) | −130.2 | −128.4 | 0.41 |
| KMT2A SRX2323891 | 293 Kidney | 941 / 17767 (5.3%) | 3567 / 177670 (2.0%) | −130.2 | −128.3 | 2.64 |
| ESR1 SRX3110723 | MCF-7 Breast | 248 / 17767 (1.4%) | 8648 / 177670 (4.9%) | −129.9 | −128.1 | 0.29 |
| FOXA1 SRX3923511 | MCF-7 Breast | 169 / 17767 (1.0%) | 7227 / 177670 (4.1%) | −129.9 | −128.0 | 0.23 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 767 / 17767 (4.3%) | 16514 / 177670 (9.3%) | −129.8 | −127.9 | 0.46 |
| GFP SRX6949256 | HeLa Uterus | 494 / 17767 (2.8%) | 12570 / 177670 (7.1%) | −129.8 | −127.9 | 0.39 |
| MAU2 SRX11120892 | MCF-7 Breast | 185 / 17767 (1.0%) | 7518 / 177670 (4.2%) | −129.7 | −127.9 | 0.25 |
| PBX3 SRX190343 | SK-N-SH Neural | 923 / 17767 (5.2%) | 18652 / 177670 (10.5%) | −129.7 | −127.9 | 0.49 |
| ESR1 SRX2513521 | MCF-7 Breast | 216 / 17767 (1.2%) | 8080 / 177670 (4.5%) | −129.7 | −127.8 | 0.27 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1728 / 17767 (9.7%) | 8875 / 177670 (5.0%) | −129.7 | −127.8 | 1.95 |
| CTNNB1 SRX833403 | hESC H1 Pluripotent stem cell | 128 / 17767 (0.7%) | 6429 / 177670 (3.6%) | −129.6 | −127.8 | 0.20 |
| FOXA1 SRX3931073 | MCF-7 Breast | 268 / 17767 (1.5%) | 8972 / 177670 (5.0%) | −129.5 | −127.7 | 0.30 |
| JUNB SRX10119384 | MCF 10A Breast | 281 / 17767 (1.6%) | 9191 / 177670 (5.2%) | −129.4 | −127.5 | 0.31 |
| RXRB SRX2636027 | Hep G2 Liver | 490 / 17767 (2.8%) | 12486 / 177670 (7.0%) | −129.1 | −127.2 | 0.39 |
| FOXA1 SRX6860635 | T-47D Breast | 346 / 17767 (1.9%) | 10243 / 177670 (5.8%) | −129.0 | −127.2 | 0.34 |
| ESR1 SRX2881001 | MCF-7 Breast | 249 / 17767 (1.4%) | 8628 / 177670 (4.9%) | −128.9 | −127.1 | 0.29 |
| FOS SRX150664 | HUVEC Cardiovascular | 602 / 17767 (3.4%) | 14129 / 177670 (8.0%) | −128.8 | −127.0 | 0.43 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 403 / 17767 (2.3%) | 11138 / 177670 (6.3%) | −128.8 | −126.9 | 0.36 |
| ARID5B SRX10475138 | Hep G2 Liver | 749 / 17767 (4.2%) | 16208 / 177670 (9.1%) | −128.4 | −126.6 | 0.46 |
| ZEB1 SRX13298923 | MCF-7 Breast | 189 / 17767 (1.1%) | 7548 / 177670 (4.2%) | −128.3 | −126.4 | 0.25 |
| NFYB SRX16608147 | HeLa Uterus | 240 / 17767 (1.4%) | 201 / 177670 (0.1%) | −128.2 | −126.3 | 11.94 |
| FOSL2 SRX190224 | MCF-7 Breast | 165 / 17767 (0.9%) | 7099 / 177670 (4.0%) | −128.1 | −126.3 | 0.23 |
| KMT2C SRX1787675 | MCF-7 Breast | 397 / 17767 (2.2%) | 11023 / 177670 (6.2%) | −128.1 | −126.3 | 0.36 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 468 / 17767 (2.6%) | 12112 / 177670 (6.8%) | −128.1 | −126.2 | 0.39 |
| ZFX SRX7805372 | 293 Kidney | 1499 / 17767 (8.4%) | 7285 / 177670 (4.1%) | −128.0 | −126.2 | 2.06 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 778 / 17767 (4.4%) | 2636 / 177670 (1.5%) | −128.0 | −126.2 | 2.95 |
| FOS SRX070879 | HUVEC Cardiovascular | 491 / 17767 (2.8%) | 12451 / 177670 (7.0%) | −127.8 | −126.0 | 0.39 |
| EP300 SRX2671806 | iPS cells Pluripotent stem cell | 87 / 17767 (0.5%) | 5522 / 177670 (3.1%) | −127.8 | −125.9 | 0.16 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 203 / 17767 (1.1%) | 115 / 177670 (0.1%) | −127.5 | −125.7 | 17.65 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1295 / 17767 (7.3%) | 5896 / 177670 (3.3%) | −127.4 | −125.6 | 2.20 |
| ESR1 SRX1012628 | MCF-7 Breast | 233 / 17767 (1.3%) | 8298 / 177670 (4.7%) | −127.3 | −125.5 | 0.28 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1359 / 17767 (7.6%) | 6337 / 177670 (3.6%) | −127.2 | −125.3 | 2.14 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 621 / 17767 (3.5%) | 14333 / 177670 (8.1%) | −127.0 | −125.2 | 0.43 |
| ESR1 SRX5323872 | MCF-7 Breast | 455 / 17767 (2.6%) | 11878 / 177670 (6.7%) | −127.0 | −125.2 | 0.38 |
| TRPS1 SRX3401273 | MCF-7 Breast | 151 / 17767 (0.8%) | 6800 / 177670 (3.8%) | −126.9 | −125.1 | 0.22 |
| CHD7 SRX3581504 | iPS cells Pluripotent stem cell | 93 / 17767 (0.5%) | 5616 / 177670 (3.2%) | −126.5 | −124.6 | 0.17 |
| NR3C1 SRX10976921 | A549 Lung | 328 / 17767 (1.8%) | 9861 / 177670 (5.6%) | −126.4 | −124.6 | 0.33 |
| ESR1 SRX1012625 | MCF-7 Breast | 241 / 17767 (1.4%) | 8403 / 177670 (4.7%) | −126.3 | −124.4 | 0.29 |
| VGLL1 SRX18013278 | FULVR Breast | 226 / 17767 (1.3%) | 8141 / 177670 (4.6%) | −126.2 | −124.4 | 0.28 |
| ESR1 SRX2513519 | MCF-7 Breast | 249 / 17767 (1.4%) | 8539 / 177670 (4.8%) | −126.1 | −124.3 | 0.29 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 684 / 17767 (3.8%) | 15190 / 177670 (8.5%) | −126.0 | −124.2 | 0.45 |
| STAT3 SRX2020847 | MDA-MB-468 Breast | 324 / 17767 (1.8%) | 9777 / 177670 (5.5%) | −125.8 | −124.0 | 0.33 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 553 / 17767 (3.1%) | 13287 / 177670 (7.5%) | −125.6 | −123.8 | 0.42 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 626 / 17767 (3.5%) | 14345 / 177670 (8.1%) | −125.6 | −123.8 | 0.44 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 193 / 17767 (1.1%) | 99 / 177670 (0.1%) | −125.5 | −123.7 | 19.49 |
| TEAD3 SRX2636153 | Hep G2 Liver | 1067 / 17767 (6.0%) | 20381 / 177670 (11.5%) | −125.4 | −123.6 | 0.52 |
| ESR1 SRX4451214 | MCF-7 Breast | 399 / 17767 (2.2%) | 10954 / 177670 (6.2%) | −125.4 | −123.6 | 0.36 |
| NFIL3 SRX2630334 | Hep G2 Liver | 374 / 17767 (2.1%) | 10564 / 177670 (5.9%) | −125.4 | −123.6 | 0.35 |
| EP300 SRX717860 | HeLa Uterus | 298 / 17767 (1.7%) | 9323 / 177670 (5.2%) | −125.0 | −123.2 | 0.32 |
Showing first 500 of 17543 rows.